title: Characterization of binding and utilization of hemoglobin by Prevotella nigrescens.
abstract: The ability of Prevotella nigrescens to utilize and bind to hemoglobin was investigated. Growth studies showed that P. nigrescens was able to utilize hemoglobin efficiently as an iron source. Binding of P. nigrescens to hemoglobin was demonstrated by dot blot assay. Heat and trypsin treatments of the bacteria led to a decrease in activity. Globin gave nearly complete inhibition of activity. Additionally, lactoferrin partially inhibited activity. In contrast, transferrin, cytochrome C and catalase exerted little or no inhibitory effect. Although the sugars tested did not affect activity, several of the amino acids tested, including arginine, cysteine, histidine and lysine, inhibited activity. In a solid phase assay, 41-, 56- and 59-kDa proteins of P. nigrescens reacted with hemoglobin. These results suggest that P. nigrescens utilizes hemoglobin for growth and 41-, 56- and 59-kDa proteins may be involved in hemoglobin binding.
authors.affiliation: Department of Preventive Dentistry, Graduate School of Dentistry, Osaka University, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Guan
authors.forename: H
authors.initials: H
authors.lastname: Nagata
authors.forename: M
authors.initials: M
authors.lastname: Kuboniwa
authors.forename: Y
authors.initials: Y
authors.lastname: Ikawa
authors.forename: K
authors.initials: K
authors.lastname: Maeda
authors.forename: S
authors.initials: S
authors.lastname: Shizukuishi
mesh_terms: D001120:Arginine / Q000494:pharmacology; D001426:Bacterial Proteins / Q000378:metabolism; D002374:Catalase / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D003574:Cytochrome c Group / Q000494:pharmacology; D004187:Disaccharides / Q000494:pharmacology; D005914:Globins / Q000494:pharmacology; D006454:Hemoglobins / Q000378:metabolism*; D006601:Hexoses / Q000494:pharmacology; D006639:Histidine / Q000494:pharmacology; D006358:Hot Temperature; D006801:Humans; D015151:Immunoblotting; D007501:Iron / Q000378:metabolism; D007781:Lactoferrin / Q000494:pharmacology; D008239:Lysine / Q000494:pharmacology; D018720:Prevotella / Q000145:classification / Q000254:growth & development / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects; D014168:Transferrin / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
chemical_list: D001426:Bacterial Proteins; D003574:Cytochrome c Group; D004187:Disaccharides; D006454:Hemoglobins; D006601:Hexoses; D014168:Transferrin; D006639:Histidine; D005914:Globins; D001120:Arginine; D007501:Iron; D002374:Catalase; D007781:Lactoferrin; D014357:Trypsin; D008239:Lysine; D003545:Cysteine